199 related articles for article (PubMed ID: 21412926)
1. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.
Toth G; Zraly CB; Thomson TL; Jones C; Lapetino S; Muraskas J; Zhang J; Dingwall AK
Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926
[TBL] [Abstract][Full Text] [Related]
2. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
[TBL] [Abstract][Full Text] [Related]
3. Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion.
Bosse KR; Shukla AR; Pawel B; Chikwava KR; Santi M; Tooke L; Castagna K; Biegel JA; Bagatell R
Cancer Genet; 2014 Sep; 207(9):415-9. PubMed ID: 25018128
[TBL] [Abstract][Full Text] [Related]
4. Congenital extrarenal malignant rhabdoid tumor in an infant with distal 22q11.2 deletion syndrome: the importance of SMARCB1.
Chakrapani AL; White CR; Korcheva V; White K; Lofgren S; Zonana J; Moore S; Krol A; Mansoor A
Am J Dermatopathol; 2012 Aug; 34(6):e77-80. PubMed ID: 22814326
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
[TBL] [Abstract][Full Text] [Related]
6. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour.
Beddow RA; Smith M; Kidd A; Corbett R; Hunter AG
Eur J Med Genet; 2011; 54(3):295-8. PubMed ID: 21187175
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
9. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
10. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.
Taylor MD; Gokgoz N; Andrulis IL; Mainprize TG; Drake JM; Rutka JT
Am J Hum Genet; 2000 Apr; 66(4):1403-6. PubMed ID: 10739763
[TBL] [Abstract][Full Text] [Related]
11. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
Takita J; Chen Y; Kato M; Ohki K; Sato Y; Ohta S; Sugita K; Nishimura R; Hoshino N; Seki M; Sanada M; Oka A; Hayashi Y; Ogawa S
Cancer Sci; 2014 Mar; 105(3):258-64. PubMed ID: 24418192
[TBL] [Abstract][Full Text] [Related]
13. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract][Full Text] [Related]
15. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
[TBL] [Abstract][Full Text] [Related]
16. Frequent breakpoints of focal deletion and uniparental disomy in 22q11.1 or 11.2 segmental duplication region reveal distinct tumorigenesis in rhabdoid tumor of the kidney.
Haruta M; Arai Y; Okita H; Tanaka Y; Takimoto T; Kamijo T; Oue T; Souzaki R; Taguchi T; Kuwahara Y; Chin M; Nakadate H; Hiyama E; Ishida Y; Koshinaga T; Kaneko Y
Genes Chromosomes Cancer; 2021 Aug; 60(8):546-558. PubMed ID: 33896058
[TBL] [Abstract][Full Text] [Related]
17. A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.
Coccé MC; Lubieniecki F; Kordes U; Alderete D; Gallego MS
J Neurooncol; 2011 Aug; 104(1):375-80. PubMed ID: 21127945
[TBL] [Abstract][Full Text] [Related]
18. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney.
Wieser R; Fritz B; Ullmann R; Müller I; Galhuber M; Storlazzi CT; Ramaswamy A; Christiansen H; Shimizu N; Rehder H
Hum Mutat; 2005 Aug; 26(2):78-83. PubMed ID: 15957176
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
[TBL] [Abstract][Full Text] [Related]
20. Array analysis and molecular studies of INI1 in an infant with deletion 22q13 (Phelan-McDermid syndrome) and atypical teratoid/rhabdoid tumor.
Sathyamoorthi S; Morales J; Bermudez J; McBride L; Luquette M; McGoey R; Oates N; Hales S; Biegel JA; Lacassie Y
Am J Med Genet A; 2009 May; 149A(5):1067-9. PubMed ID: 19334084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
